ALCL


Also found in: Dictionary, Thesaurus, Medical, Encyclopedia.
Related to ALCL: ACL
AcronymDefinition
ALCLAnaplastic Large Cell Lymphoma
ALCLAssembly Line Communications Link
ALCLAssociation of London Chief Librarians (UK)
ALCLAngiotropic Large Cell Lymphoma (oncology)
ALCLAsian Leasing Corporation Limited (Pakistan)
References in periodicals archive ?
"While chemotherapy is known to be effective for ALCL, there is a strong need for development of new therapeutic options since recurrent ALCL often carries a poor prognosis," said Dr.
"[The] case helps to demonstrate that many textured implants could potentially be [a] risk [factor] for ALCL and that in general, the discussion should move from 'breast implant-associated cancer' to 'implant-associated [cancer],' to better encompass the full spectrum of disease," the researchers wrote.
Twenty patients with high-risk ALCL relapses or refractory were treated by allo-HSCT with TBI-based regimen and the probability of 3-year even-free survival after allo-HSCT was 75% [+ or -] 10%.[12] There need more clinical data to confirm this superiority of TBI in patients with PTCL.
ALCL was given 30 minutes before DONZ and CM extract to avoid possible interactions between aluminum and other substances.
ALCL is further subclassified based on positive or negative ALK protein expression.
(354) In addition to widely recognized risks, evidence suggests implants also carry potential risks related to triggering the onset of autoimmune disease and a small but increased risk of ALCL. (355) Congressional investigation of this topic and materials discovered during litigation demonstrated how the lack of pertinent safety studies assessing long term safety blurs the ability for physicians to assess the weight of evidence pertaining to potential product risk on patients.
Banham et al., "B and CTL responses to the ALK protein in patients with ALK-positive ALCL," International Journal of Cancer, vol.
However, approximately 10% to 20% of patients with LyP may present with a lymphoproliferative malignancy such as CD30 anaplastic large cell lymphoma (ALCL), mycosis fungoides (MF), or Hodgkin disease [5, 6].
Zhao and colleagues targeted the CD30 surface biomarker found primarily on anaplastic large cell lymphomas (ALCL) [82].
Given the in situ subtype of ALCL noted in our patient, she underwent capsulectomy with no other local or systemic therapy.
Single cases have been described of the combination of CLL/SLL and anaplastic large-cell lymphoma (ALCL) [2, 3], T-cell large granular leukemia [4, 5], subcutaneous panniculitis-like T-cell lymphoma [6], cutaneous gamma-delta T-cell lymphoma [7], mycosis fungoides [8], and peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS) [8-12].